Takehara Sayaka, Onda Maki, Zhang Juan, Nishiyama Mika, Yang Xiaoyan, Mikami Bunzo, Lomas David A
Division of Applied Life Sciences, The Graduate School of Agriculture, Kyoto University, Uji 611-0011, Japan.
J Mol Biol. 2009 Apr 24;388(1):11-20. doi: 10.1016/j.jmb.2009.03.007. Epub 2009 Mar 10.
Neuroserpin is a selective inhibitor of tissue-type plasminogen activator (tPA) that plays an important role in neuronal plasticity, memory, and learning. We report here the crystal structure of native human neuroserpin at 2.1 A resolution. The structure has a helical reactive center loop and an omega loop between strands 1B and 2B. The omega loop contributes to the inhibition of tPA, as deletion of this motif reduced the association rate constant with tPA by threefold but had no effect on the kinetics of interaction with urokinase. Point mutations in neuroserpin cause the formation of ordered intracellular polymers that underlie dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB). Wild-type neuroserpin is also unstable and readily forms polymers under near-physiological conditions in vitro. This is, in part, due to the substitution of a conserved alanine for serine at position 340. The replacement of Ser340 by Ala increased the melting temperature by 3 degrees C and reduced polymerization as compared to wild-type neuroserpin. Similarly, neuroserpin has Asn-Leu-Val at the end of helix F and thus differs markedly from the Gly-X-Ile consensus sequence of the serpins. Restoration of these amino acids to the consensus sequence increased thermal stability and reduced the polymerization of neuroserpin and its transition to the latent conformer. Moreover, introduction of the consensus sequence into S49P neuroserpin that causes FENIB increased the stability and inhibitory activity of the mutant, as well as blocked polymerization and increased the yield of protein during refolding. These data provide a molecular explanation for the inherent instability of neuroserpin and the effect of point mutations that underlie the dementia FENIB.
神经丝氨酸蛋白酶抑制剂是组织型纤溶酶原激活剂(tPA)的选择性抑制剂,在神经元可塑性、记忆和学习中发挥重要作用。我们在此报告分辨率为2.1埃的天然人神经丝氨酸蛋白酶抑制剂的晶体结构。该结构具有螺旋反应中心环以及在1B和2B链之间的ω环。ω环有助于抑制tPA,因为缺失该基序会使与tPA的结合速率常数降低三倍,但对与尿激酶的相互作用动力学没有影响。神经丝氨酸蛋白酶抑制剂中的点突变会导致形成有序的细胞内聚合物,这是伴有神经丝氨酸蛋白酶抑制剂包涵体的痴呆性家族性脑病(FENIB)的基础。野生型神经丝氨酸蛋白酶抑制剂也不稳定,在体外接近生理条件下很容易形成聚合物。这部分是由于在340位将保守的丙氨酸替换为丝氨酸。与野生型神经丝氨酸蛋白酶抑制剂相比,将丝氨酸340替换为丙氨酸可使解链温度提高3摄氏度并减少聚合。同样,神经丝氨酸蛋白酶抑制剂在螺旋F末端具有天冬酰胺 - 亮氨酸 - 缬氨酸,因此与丝氨酸蛋白酶抑制剂的甘氨酸 - X - 异亮氨酸共有序列明显不同。将这些氨基酸恢复为共有序列可提高热稳定性并减少神经丝氨酸蛋白酶抑制剂的聚合及其向潜在构象的转变。此外,将共有序列引入导致FENIB的S49P神经丝氨酸蛋白酶抑制剂中,可提高突变体的稳定性和抑制活性,同时阻止聚合并提高重折叠过程中蛋白质的产量。这些数据为神经丝氨酸蛋白酶抑制剂的固有不稳定性以及作为痴呆性FENIB基础的点突变的影响提供了分子解释。